ADIPOQ and chronic kidney disease: Paradoxically, the levels of both adiponectin and leptin, known, respectively, for their anti- and proinflammatory effects, and for their negative and positive correlation with BMI, are elevated in CKD, and have been associated with progression of renal dysfunction.